A Common Pro-opiomelanocortin-binding Element Mediates Leukemia Inhibitory Factor and Corticotropin-releasing Hormone Transcriptional Synergy
Corinne Bousquet(Centre National de la Recherche Scientifique), Шломо Мелмед(Salk Institute for Biological Studies), David Ray(John Radcliffe Hospital)
Cited by 71
Related Papers
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Genome-wide association study identifies genetic loci for self-reported habitual sleep duration supported by accelerometer-derived estimates
|Nature Communications|2019|652
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
|The Lancet|2001|643
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Biological and clinical insights from genetics of insomnia symptoms
|Nature Genetics|2019|417